sing Tranexamic Acid with Oxytocin to Prevent Excessive Bleeding After C-Sections
Not Applicable
- Conditions
- Health Condition 1: O722- Delayed and secondary postpartum hemorrhage
- Registration Number
- CTRI/2024/04/065359
- Lead Sponsor
- jawaharlal nehru medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Scheduled or unscheduled cesarean delivery of all age groups and partiy
Singleton or twin gestation
Exclusion Criteria
Severe medical and surgical complications
History of allergy to tranexamic acid
History of thrombi-embolic disorders.
Antenatal complications like, abnormal placenta
placenta-previa, placenta abruption, adherent placenta, severe preeclampsia, Multiple pregnancies, macrosomia, polyhydramnios,
Fibroid uterus or gynecological disorders complicating pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in blood loss between the two groups In women receiving tranexamic acid <br/ ><br>In women receiving placebo <br/ ><br>Post operatively up to 6 hours in the same two groups <br/ ><br>Side effects related to drug used.. <br/ ><br>Timepoint: 6 HOURS
- Secondary Outcome Measures
Name Time Method The difference in following parameters in the two groups <br/ ><br>Hemoglobin/haematocrit <br/ ><br>Need for additional uterotonics <br/ ><br>Need for blood transfusion <br/ ><br>Timepoint: 6 HOURS